Seniors aged 75 and above are now eligible to schedule appointments for RSV vaccination in Newfoundland and Labrador, following an expansion of the program announced earlier. The vaccination clinics will be operational throughout the province from October 13 to 18, with booking options available online via Newfoundland and Labrador Health Services or by phone at 833-951-3884.
RSV, a highly contagious virus that primarily affects the respiratory tract, poses a greater risk to seniors and infants, potentially leading to respiratory distress. Dr. Janice Fitzgerald, the chief medical officer of health for Newfoundland and Labrador, emphasized the importance of immunization as the most effective way to prevent severe RSV infections and associated complications.
Notably, cases of RSV have already been reported this season, with peak numbers typically observed around November and post-Christmas. The provincial government, under the Progressive Conservative leadership, had earmarked $3.9 million in the budget to expand vaccine eligibility in April, making the vaccine accessible to seniors over 75 and infants under six months.
Health Minister Joedy Wall highlighted the substantial reduction in hospital admissions for RSV cases, citing data from the National Advisory Committee on Immunization that indicated over an 80% decrease with vaccinations. Lynette Bowes, a pediatrician in St. John’s and the clinical chief of children’s and women’s health for the Eastern zone, expressed optimism that the expanded vaccination program would alleviate the burden on parents and infants during the peak respiratory admissions period.
Since May, newborns have been offered the vaccine before discharge from the hospital, with initial uptake ranging from 80 to 85%. Fitzgerald encouraged parents to ensure their babies are vaccinated promptly before leaving the hospital, emphasizing the immediate efficacy of the vaccine compared to traditional vaccines that require a waiting period to take effect.
The overall sentiment among healthcare professionals is positive, with the hope that the expanded vaccination program will lead to a decrease in severe RSV cases, particularly among vulnerable populations.